Literature DB >> 34201050

Prognostic Relevance of CD4+, CD8+ and FOXP3+ TILs in Oral Squamous Cell Carcinoma and Correlations with PD-L1 and Cancer Stem Cell Markers.

Paloma Lequerica-Fernández1,2, Julián Suárez-Canto3, Tania Rodriguez-Santamarta2,4, Juan Pablo Rodrigo2,5,6,7, Faustino Julián Suárez-Sánchez1, Verónica Blanco-Lorenzo8, Francisco Domínguez-Iglesias1, Juana María García-Pedrero2,7, Juan Carlos de Vicente2,4,6.   

Abstract

This study investigates the relevance of tumor-infiltrating lymphocytes (TILs) in oral squamous cell carcinoma (OSCC). Immunohistochemical analysis of stromal/tumoral CD4+, CD8+ and FOXP3+ TILs is performed in 125 OSCC patients. Potential relationships with the expression of tumoral PD-L1 and cancer stem cell (CSC) markers (NANOG, SOX2, OCT4, Nestin and Podoplanin (PDPN)) are assessed. CD4+ and CD8+ TILs are significantly associated with smoking and alcohol habits. CD4+ and CD8+ TILs show an inverse relationship with NANOG and SOX2 expression, and FOXP3+ TILs is significantly correlated with Nestin and PDPN expression. High infiltration of CD4+ and CD8+ TILs and a high tumoral CD8+/FOXP3+ ratio are significantly associated with tumors harboring positive PD-L1 expression. Infiltration of stromal/tumoral FOXP3+ TILs and a low stromal CD8+/FOXP3+ ratio are significantly associated with better disease-specific survival. Multivariate analysis reveals that the stromal CD8+/FOXP3+ TILs ratio is a significant independent prognostic factor. Regarding OSCC patient survival, the CD8+/FOXP3+ TILs ratio is an independent prognostic factor. TILs may act as biomarkers and potential therapeutic targets for OSCC.

Entities:  

Keywords:  CD4; CD8; FOXP3; Nestin; OCT4; Podoplanin; TILs; oral cancer

Year:  2021        PMID: 34201050     DOI: 10.3390/biomedicines9060653

Source DB:  PubMed          Journal:  Biomedicines        ISSN: 2227-9059


  4 in total

1.  Models for Oral Biology Research.

Authors:  Fernando Capela E Silva; Elsa Lamy; Paula Midori Castelo
Journal:  Biomedicines       Date:  2022-04-20

2.  Beyond PD-L1-Identification of Further Potential Therapeutic Targets in Oral Cancer.

Authors:  Manuel Weber; Rainer Lutz; Manuel Olmos; Jacek Glajzer; Christoph Baran; Christopher-Philipp Nobis; Tobias Möst; Markus Eckstein; Marco Kesting; Jutta Ries
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

3.  Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.

Authors:  Wattawan Wongpattaraworakul; Katherine N Gibson-Corley; Allen Choi; Marisa R Buchakjian; Emily A Lanzel; Anand Rajan Kd; Andrean L Simons
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

4.  T-Cell Infiltration and Immune Checkpoint Expression Increase in Oral Cavity Premalignant and Malignant Disorders.

Authors:  Subin Surendran; Usama Aboelkheir; Andrew A Tu; William J Magner; S Lynn Sigurdson; Mihai Merzianu; Wesley L Hicks; Amritha Suresh; Keith L Kirkwood; Moni A Kuriakose
Journal:  Biomedicines       Date:  2022-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.